Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Neurocrine Biosciences Inc
Today
Create an eToro account to buy NBIX stock on a secure, user-friendly, multi-asset trading platform.
Buy Neurocrine Biosciences Inc
Buy Neurocrine Biosciences Inc
Neurocrine Biosciences Inc NBIX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
171.17
Based on analysts who covered NBIX
Stocks-NBIX-Neurocrine Biosciences Inc

Neurocrine Biosciences Inc NBIX

$107.22-3.65(-3.29%)(1D)
Nasdaqin USD

NBIX Stock Price Chart

‎-7.77‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Neurocrine Biosciences Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Neurocrine Biosciences Inc share price today is $107.22, reflecting a ‎-3.29‎% change over the last 24 hours and ‎-5.62‎% over the past week. The current market capitalization of NBIX is 10.69B with an average volume in the last three months of 1.31M. The stock has a P/E ratio of 32.58 and a dividend yield of 0%. With the stock’s beta sitting at 0.55
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$10.69B

Day’s Range
i
Shows the high and low prices of the day.
105 - 120.55

52W Range
i
Shows the high and low prices of the last year.
103.38 - 156.73

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.31M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
32.58

Revenue
i
The total income generated by this company’s goods and services last year.
$2.36B

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$107.22

EPS
i
A company’s total earnings divided by the number of shares it has issued.
3.29

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.55

What Is Neurocrine Biosciences Inc?
Neurocrine Biosciences Inc is an American biopharmaceutical company headquartered in San Diego, California. Operating globally, the firm was founded in 1992 and has a focus on neuroscience. It is primarily engaged in the discovery, development, and commercialisation of a range of life-changing treatments for patients with serious and under-addressed neurological and endocrine-related diseases and psychiatric disorders.

The company develops drugs for women’s health issues such as endometriosis, uterine fibroids, and polycystic ovary syndrome. It is also involved in drug discovery for neurological diseases such as Parkinson’s disease and tardive dyskinesia, as well as for other disorders ranging from anxiety, depression, and anhedonia to epilepsy, schizophrenia, and congenital adrenal hyperplasia (CAH). Neurocrine Biosciences Inc specialises in the targeting and interruption of disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.

Commercial products available from Neurocrine Biosciences include Ingrezza, used to treat adult patients with tardive dyskinesia (TD), and Ongentys, a medicine used with levodopa and carbidopa in people with Parkinson’s disease (PD). The firm’s stock is listed on the Nasdaq Global Select Market, where it trades under the stock ticker NBIX.

Add Neurocrine Biosciences Inc to your eToro watchlist to start monitoring NBIX price movements and receive real-time updates.

How can I buy Neurocrine Biosciences Inc stocks?

To purchase Neurocrine Biosciences Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Neurocrine Biosciences Inc (NBIX) page and place an order to buy Neurocrine Biosciences Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Neurocrine Biosciences Inc
Invest in Neurocrine Biosciences Inc
Today
Create an eToro account to buy NBIX stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of NBIX is $107.22.
The average price target for Neurocrine Biosciences Inc is $107.22. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Neurocrine Biosciences Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Neurocrine Biosciences Inc is $10.69B
Scroll to top